| SI-BONE INC. DL-,0001 |
| USA |
| Gesundheit |
| US8257041090 / A2N7LY |
| 2K3 (Frankfurt) / SIBN (NASDAQ) |
| FRA:2K3, ETR:2K3, 2K3:GR, NASDAQ:SIBN |
| - |
| https://si-bone.com/ |
|
Si-Bone Inc. is a prominent medical device company specializing in the development and commercialization of minimally invasive surgical implants for the treatment of sacroiliac joint dysfunction. Known for its iFuse Implant System, the company's prim..
>Volltext.. |
| 497.78 Mio. EUR |
| 403.2 Mio. EUR |
| 174.07 Mio. EUR |
| -14.35 Mio. EUR |
| -16.38 Mio. EUR |
| -0.38 EUR |
| 31.78 Mio. EUR |
| 36.59 Mio. EUR |
| -0.58 Mio. EUR |
| 5.85 |
| 5.93% |
| 46.09% |
| - |
| - |
| - |
| SI-BONE, SI BONE |
| 05.04.26 |
|